Daratumumab (DARA), an immunoglobulin that targets CD38 on myeloma cells, was recently approved by the U.S. FDA. DARA, however, also…
Quality Control and Regulatory
Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
Privacy Policy
